Dec 23, 2025 8:00 am EST Profound Medical Corp. Closes $36 Million Registered Direct Offering; Expects to Complete Subsequent Private Placement On or Before December 30th
Dec 19, 2025 8:45 am EST Profound Medical Corp. Announces Pricing of up to $40 Million Financing Comprised of a $36 Million Registered Direct Offering and a Subsequent $4 Million Private Placement
Dec 4, 2025 5:00 pm EST Stanford Medicine’s Dr. Pejman Ghanouni Receives RSNA’s Cum Laude Award for CAPTAIN Perioperative Data Presentation
Nov 18, 2025 4:15 pm EST Profound Medical Celebrates The Hong Center’s 200th Independent TULSA Procedure for Prostate Disease
Nov 12, 2025 8:30 am EST Profound Medical Announces Strategic Distribution Agreement with Getz Healthcare to Bring TULSA-PRO® to Australia and New Zealand
Nov 11, 2025 4:15 pm EST Profound Medical Inks Exclusive Distribution Agreement for TULSA-PRO® and Sonalleve® with Al Faisaliah Medical Systems in Saudi Arabia
Nov 10, 2025 4:30 pm EST Profound Medical Regains Exclusive Distribution Rights for TULSA-PRO® in Canada from Knight